Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people with ...

The new Trump administration should seize the opportunity to change the Medicare drug price negotiation program by ...

Trump has reversed some of President Biden’s initiatives, including $2 monthly out-of-pocket cap on some generics and ...

Transparency in the program is more than just a mechanism for fair pricing—it is a driving force that diminishes the returns ...

On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in ...

Trump’s executive order halts an effort to cap the copayment for generic medications at $2 for Medicare beneficiaries.

The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, ...

The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...

Experts suggest that most Americans will not experience immediate changes in their out-of-pocket health care expenses.

Although Medicare enrollees typically don't pay a premium for Part A, which covers hospital care, there's a cost for being ...

The talks around drugs including Novo Nordisk’s Wegovy, GSK’s Trelegy Ellipta, and Pfizer’s Xtandi will set Medicare prices ...

Medicare announced plans to negotiate lower prices for 15 costly drugs, including Ozempic, Wegovy, and Trelegy Ellipta, ...